Novavax lays off 25% of workforce, releases 2023 outlook
May 9 (Reuters) – COVID-19 vaccine maker Novavax Inc (NVAX.O) on Tuesday forecast much higher 2023 revenue than Wall Street expected and announced plans to cut a quarter of its workforce, spurring hopes of a recovery for the cash-strapped biotech, and its shares jumped 40%.In February, the company raised doubts about its ability to remain… […]